FDA Takes Steps to Increase Racial and Ethnic Diversity in Clinical Trials
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently issued new draft guidance to industry for developing plans to enroll more participants from underrepresented racial and ethnic populations in …
FDA Takes Steps to Increase Racial and Ethnic Diversity in Clinical Trials Read More